ArticlePharmaceutics2020
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.
Panagiotis Kanellopoulos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticlePharmaceutics2020
Panagiotis Kanellopoulos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.